- Home
- MNDO vs CLNN Comparison
MNDO vs CLNN Comparison
Compare MNDO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- CLNN
- Stock Information
- Founded
- MNDO 1995
- CLNN 2012
- Country
- MNDO Israel
- CLNN United States
- Employees
- MNDO N/A
- CLNN N/A
- Industry
- MNDO EDP Services
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- CLNN Health Care
- Exchange
- MNDO Nasdaq
- CLNN Nasdaq
- Market Cap
- MNDO 40.2M
- CLNN 43.0M
- IPO Year
- MNDO 2000
- CLNN N/A
- Fundamental
- Price
- MNDO $2.01
- CLNN $4.34
- Analyst Decision
- MNDO
- CLNN Strong Buy
- Analyst Count
- MNDO 0
- CLNN 4
- Target Price
- MNDO N/A
- CLNN $55.25
- AVG Volume (30 Days)
- MNDO 20.9K
- CLNN 121.1K
- Earning Date
- MNDO 11-05-2024
- CLNN 11-13-2024
- Dividend Yield
- MNDO 12.01%
- CLNN N/A
- EPS Growth
- MNDO N/A
- CLNN N/A
- EPS
- MNDO 0.23
- CLNN N/A
- Revenue
- MNDO $21,856,000.00
- CLNN $421,000.00
- Revenue This Year
- MNDO N/A
- CLNN N/A
- Revenue Next Year
- MNDO N/A
- CLNN N/A
- P/E Ratio
- MNDO $8.72
- CLNN N/A
- Revenue Growth
- MNDO 2.27
- CLNN N/A
- 52 Week Low
- MNDO $1.70
- CLNN $3.82
- 52 Week High
- MNDO $2.28
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- MNDO 52.28
- CLNN 44.40
- Support Level
- MNDO $1.95
- CLNN $4.22
- Resistance Level
- MNDO $2.04
- CLNN $5.47
- Average True Range (ATR)
- MNDO 0.04
- CLNN 0.45
- MACD
- MNDO 0.00
- CLNN 0.06
- Stochastic Oscillator
- MNDO 55.56
- CLNN 30.57
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).